Dexamethasone vs COVID‐19: An experimental study in line with the preliminary findings of a large trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dexamethasone vs COVID‐19: An experimental study in line with the preliminary findings of a large trial

Published:2020-12-30 Issue:6 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Hosseinzadeh Mohammad Hossein¹^ORCID,Shamshirian Amir²^ORCID,Ebrahimzadeh Mohammad Ali³^ORCID

Affiliation:

1. Student Research Committee School of Pharmacy Mazandaran University of Medical Sciences Sari Iran

2. Gastrointestinal Cancer Research Center Non‐Communicable Diseases Institute Mazandaran University of Medical Sciences Sari Iran

3. Pharmaceutical Sciences Research Center Department of Medicinal Chemistry School of Pharmacy Mazandaran University of Medical Science Sari Iran

Funder

Mazandaran University of Medical Sciences

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.13943

Reference27 articles.

1. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries

2. ACUTE RESPIRATORY DISTRESS IN ADULTS

3. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial

4. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curcuma longa alone and in combination with pioglitazone attenuates paraquat-induced lung injury in rats through improving inflammation, oxidative stress and fibrosis;Journal of Traditional and Complementary Medicine;2023-12

2. Mapping the Lipid Signatures in COVID-19 Infection: Diagnostic and Therapeutic Solutions;Journal of Medicinal Chemistry;2023-10-30

3. Leukopenia and leukocytosis as strong predictors of COVID‐19 severity: A cross‐sectional study of the hematologic abnormalities and COVID‐19 severity in hospitalized patients;Health Science Reports;2023-09-27

4. Autoimmune complications of COVID-19 and potential consequences for long-lasting disease syndromes;Transfusion and Apheresis Science;2023-02

5. Discovery of All-d-Peptide Inhibitors of SARS-CoV-2 3C-like Protease;ACS Chemical Biology;2023-01-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3